Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug;8(7):719-721.
doi: 10.21037/qims.2018.07.08.

The role of delta radiomics in gastric cancer

Affiliations

The role of delta radiomics in gastric cancer

Maria Antonietta Mazzei et al. Quant Imaging Med Surg. 2018 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
A 67-year-old man with advanced gastric cancer of the lesser curvature who underwent contrast enhanced CT pre (A) and post (B) NAC. Although the post-NAC CT clearly shows a reduction in the size of tumoral mass, delta parameters (entropy, GLCM-contrast, GLCM-entropy, GLCM-dissimilarity) classify this patient as non-responder. The finding is confirmed on final histopathology after surgery (adenocarcinoma ypT3, tumor regression grade 3 according to Becker et al.). NAC, neoadjuvant chemotherapy; CT, computed tomography; GLCM, grey-level co-occurrence matrix.

References

    1. Hou Z, Yang Y, Li S, Yan J, Ren W, Liu J, Wang K, Liu B, Wan S. Radiomic analysis using contrast-enhanced CT: predict treatment response to pulsed low dose rate radiotherapy in gastric carcinoma with abdominal cavity metastasis. Quant Imaging Med Surg 2018;8:410-20. 10.21037/qims.2018.05.01 - DOI - PMC - PubMed
    1. Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. Radiographics 2017;37:1483-503. 10.1148/rg.2017170056 - DOI - PubMed
    1. Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer 2016;19:329-38. 10.1007/s10120-015-0575-z - DOI - PMC - PubMed
    1. De Manzoni G, Marrelli D, Baiocchi GL, Morgagni P, Saragoni L, Degiuli M, Donini A, Fumagalli U, Mazzei MA, Pacelli F, Tomezzoli A, Berselli M, Catalano F, Di Leo A, Framarini M, Giacopuzzi S, Graziosi L, Marchet A, Marini M, Milandri C, Mura G, Orsenigo E, Quagliuolo V, Rausei S, Ricci R, Rosa F, Roviello G, Sansonetti A, Sgroi G, Tiberio GA, Verlato G, Vindigni C, Rosati R, Roviello F. The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer 2017;20:20-30. 10.1007/s10120-016-0615-3 - DOI - PubMed
    1. Mazzei MA, Khader L, Cirigliano A, Cioffi Squitieri N, Guerrini S, Forzoni B, Marrelli D, Roviello F, Mazzei FG, Volterrani L. Accuracy of MDCT in the preoperative definition of peritoneal cancer index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Abdominal Imaging 2013;38:1422-30. 10.1007/s00261-013-0013-9 - DOI - PubMed

LinkOut - more resources